-
341
Examining the validity and reliability of the Persian version of the MiND‐B questionnaire in ALS patients
Published 2023-09-01Subjects: Get full text
Article -
342
Patient reported impact of symptoms in amyotrophic lateral sclerosis (PRISM-ALS): A national, cross-sectional studyResearch in context
Published 2023-01-01Subjects: Get full text
Article -
343
Optimizing breathlessness management in amyotrophic lateral sclerosis: insights from a comprehensive systematic review
Published 2024-04-01Subjects: Get full text
Article -
344
Amyotrophic Lateral Sclerosis and Myasthenia Gravis: Comorbidities and Differential Diagnosis
Published 2025-01-01Subjects: Get full text
Article -
345
Ultrasound-guided glenohumeral joint injections for shoulder pain in ALS: A case series
Published 2023-02-01Subjects: Get full text
Article -
346
Pain in amyotrophic lateral sclerosis: a narrative review
Published 2022-07-01Subjects: Get full text
Article -
347
Corrigendum: An Overview of MicroRNAs as Biomarkers of ALS
Published 2019-10-01Subjects: Get full text
Article -
348
Amyotrophic lateral sclerosis with extension of the central canal of the spinal cord according to magnetic resonance imaging data
Published 2016-11-01Subjects: “…motor neuron disease…”
Get full text
Article -
349
Expanding the Availability of Onasemnogene Abeparvovec to Older Patients: The Evolving Treatment Landscape for Spinal Muscular Atrophy
Published 2023-06-01Subjects: Get full text
Article -
350
Trends in the diagnostic delay and pathway for amyotrophic lateral sclerosis patients across different countries
Published 2023-01-01Subjects: Get full text
Article -
351
O'Sullivan-McLeod Syndrome: A Case Report
Published 2022-04-01Subjects: “…motor neuron disease…”
Get full text
Article -
352
Serial MRI studies over 12 months using manual and atlas-based region of interest in patients with amyotrophic lateral sclerosis
Published 2020-08-01Subjects: Get full text
Article -
353
Identifying the primary site of pathogenesis in amyotrophic lateral sclerosis – vulnerability of lower motor neurons to proximal excitotoxicity
Published 2015-03-01Subjects: “…Motor neuron disease…”
Get full text
Article -
354
The Neurotoxicity of Vesicles Secreted by ALS Patient Myotubes Is Specific to Exosome-Like and Not Larger Subtypes
Published 2022-03-01Subjects: Get full text
Article -
355
Emotional Processing and Experience in Amyotrophic Lateral Sclerosis: A Systematic and Critical Review
Published 2021-10-01Subjects: Get full text
Article -
356
Riluzole use in presence of contraindications in adults affected by amyotrophic lateral sclerosis and its off-label use in other motor neuron diseases: Findings from an Italian multicentre study (the CAESAR project)
Published 2022-10-01“…Background: This analysis describes the use of riluzole in amyotrophic lateral sclerosis (ALS) individuals with contraindications and off-label use for subjects with other motor neuron diseases (o-MND) in the Italian regions of Latium, Tuscany and Umbria.Methods: A cohort of adults with ALS prescribed with riluzole during the years 2016–2019 was enrolled from administrative healthcare databases, excluding subjects with o-MND in the preceding 5 years. …”
Get full text
Article -
357
建立中国运动神经元病医疗规范和持续质量改进体系 Establish a Medical Standard and Continuous Quality Improvement System for Motor Neuron Disease in China
Published 2024-01-01Subjects: Get full text
Article -
358
Calcium, Mitochondria and the Pathogenesis of ALS: The Good, the Bad and the Ugly
Published 2013-10-01Subjects: Get full text
Article -
359
Protein Homeostasis in Amyotrophic Lateral Sclerosis: Therapeutic Opportunities?
Published 2017-05-01Subjects: Get full text
Article -
360
Monomelic amyotrophy: a rare variant of lower motor neuron disorder (2 clinical cases)
Published 2017-02-01Subjects: Get full text
Article